White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era
Author(s) -
Binita Shah,
Usman Baber,
Stuart J. Pocock,
Mitchell W. Krucoff,
Cono Ariti,
C. Michael Gibson,
Philippe Gabríel Steg,
Giora Weisz,
Bernhard Witzenbichler,
Timothy D. Henry,
Annapoorna Kini,
Thomas Stuckey,
David J. Cohen,
Ιoannis Iakovou,
George Dangas,
Melissa Aquino,
Samantha Sartori,
Alaide Chieffo,
David J. Moliterno,
Antonio Colombo,
Roxana Mehran
Publication year - 2017
Publication title -
circulation cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.621
H-Index - 95
eISSN - 1941-7632
pISSN - 1941-7640
DOI - 10.1161/circinterventions.117.004981
Subject(s) - medicine , mace , percutaneous coronary intervention , myocardial infarction , hazard ratio , cardiology , acute coronary syndrome , revascularization , population , proportional hazards model , confidence interval , surgery , environmental health
Elevated white blood cell (WBC) count is associated with increased major adverse cardiovascular events (MACE) in the setting of acute coronary syndrome. The aim of this study was to evaluate whether similar associations persist in an all-comers population of patients undergoing percutaneous coronary intervention in the contemporary era.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom